IQE appoints MACOM executives to board under strategic partnership agreement (IQE)

Board additions strengthen ties with major shareholder

IQE plc (LSE:IQE) has appointed MACOM Technology Solutions executives Robert Dennehy and David O’Carroll as non-executive directors, in accordance with the board appointment agreement previously established between the two companies.

The appointments further strengthen the relationship between IQE and MACOM, which holds an 11.5% stake in the compound semiconductor wafer manufacturer, and could support closer strategic alignment between the long-standing industry partners.

New directors bring extensive operational and industry experience

Dennehy, MACOM’s senior vice president and chief operating officer, brings more than 30 years of leadership and operational experience gained across Europe and the United States.

O’Carroll adds expertise in international operations, finance and government relations, with experience spanning both European and Asian markets. IQE said the appointments support its strategy of positioning the business to capture future growth opportunities, while potentially enhancing collaboration across the global semiconductor supply chain.

Financial pressures remain despite improving market momentum

IQE’s investment outlook continues to be constrained by weak financial performance, including ongoing losses, a negative gross profit reported during 2025, negative free cash flow, rising debt levels and declining shareholder equity.

These challenges are partly offset by stronger technical indicators, with the shares trading above key moving averages and supported by a positive MACD signal. However, valuation remains difficult to assess given the company’s negative earnings and the absence of a dividend.

More about IQE plc

IQE plc is a Cardiff-based manufacturer of advanced compound semiconductor wafers and engineered materials used in smart devices, communications infrastructure, automotive and industrial applications, as well as aerospace and defence technologies. The company operates epitaxy wafer manufacturing facilities in the UK, the US and Taiwan, supplying proprietary semiconductor materials to global chipmakers and original equipment manufacturers. IQE’s shares are listed on the AIM market of the London Stock Exchange.